These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32445357)

  • 21. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.
    Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Zuurman MW; van der Steege G; van Tol A; Dullaart RP;
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3382-8. PubMed ID: 16684835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.
    Yin RX; Wu DF; Miao L; Htet Aung LH; Cao XL; Yan TT; Long XJ; Liu WY; Zhang L; Li M
    Biofactors; 2013; 39(3):315-25. PubMed ID: 23355348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients.
    Liao KP; Liu J; Lu B; Solomon DH; Kim SC
    Arthritis Rheumatol; 2015 May; 67(8):2004-10. PubMed ID: 25917955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conflicting interactions of apolipoprotein A and high density lipoprotein cholesterol with microvascular complications of type 2 diabetes.
    Aryan Z; Afarideh M; Ghajar A; Esteghamati S; Esteghamati A; Nakhjavani M
    Diabetes Res Clin Pract; 2017 Nov; 133():131-141. PubMed ID: 28934670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk.
    Raitakari OT; Mäkinen VP; McQueen MJ; Niemi J; Juonala M; Jauhiainen M; Salomaa V; Hannuksela ML; Savolainen MJ; Kesäniemi YA; Kovanen PT; Sundvall J; Solakivi T; Loo BM; Marniemi J; Hernesniemi J; Lehtimäki T; Kähönen M; Peltonen M; Leiviskä J; Jula A; Anand SS; Miller R; Yusuf S; Viikari JS; Ala-Korpela M
    Atherosclerosis; 2013 Jan; 226(1):245-51. PubMed ID: 23159013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol.
    Sniderman AD; Islam S; McQueen M; Pencina M; Furberg CD; Thanassoulis G; Yusuf S
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27737874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Levels of Apolipoproteins and Incident Type 2 Diabetes: A Prospective Cohort Study.
    Brahimaj A; Ligthart S; Ikram MA; Hofman A; Franco OH; Sijbrands EJ; Kavousi M; Dehghan A
    Diabetes Care; 2017 Mar; 40(3):346-351. PubMed ID: 28031419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in serum afamin and vitamin E levels after selective LDL apheresis.
    Varga VE; Lőrincz H; Szentpéteri A; Juhász L; Seres I; Paragh G; Balla J; Paragh G; Harangi M
    J Clin Apher; 2018 Oct; 33(5):569-575. PubMed ID: 30247793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BMP1 5'UTR + 104 T/C gene variation: can be a predictive marker for serum HDL and apoprotein A1 levels in male patients with coronary heart disease.
    Akadam-Teker B; Ozkara G; Kurnaz-Gomleksiz O; Bugra Z; Teker E; Ozturk O; Yilmaz-Aydogan H
    Mol Biol Rep; 2018 Oct; 45(5):1269-1276. PubMed ID: 30062502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study.
    Saleheen D; Scott R; Javad S; Zhao W; Rodrigues A; Picataggi A; Lukmanova D; Mucksavage ML; Luben R; Billheimer J; Kastelein JJ; Boekholdt SM; Khaw KT; Wareham N; Rader DJ
    Lancet Diabetes Endocrinol; 2015 Jul; 3(7):507-13. PubMed ID: 26025389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low HDL cholesterol levels in type I Gaucher disease do not lead to an increased risk of cardiovascular disease.
    de Fost M; Langeveld M; Franssen R; Hutten BA; Groener JE; de Groot E; Mannens MM; Bikker H; Aerts JM; Kastelein JJ; Hollak CE
    Atherosclerosis; 2009 May; 204(1):267-72. PubMed ID: 18842264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between lipids and apolipoproteins on type 2 diabetes risk; moderating effects of gender and polymorphisms; the ATTICA study.
    Mellor DD; Georgousopoulou EN; D'Cunha NM; Naumovski N; Chrysohoou C; Tousoulis D; Pitsavos C; Panagiotakos DB;
    Nutr Metab Cardiovasc Dis; 2020 May; 30(5):788-795. PubMed ID: 32127339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: possible attenuation of cardioprotection associated with high HDL cholesterol.
    Dullaart RP; Perton F; van der Klauw MM; Hillege HL; Sluiter WJ;
    Atherosclerosis; 2010 Feb; 208(2):537-42. PubMed ID: 19698944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Spicy Food Consumption Frequency with Serum Lipid Profiles in Older People in China.
    Yu K; Xue Y; He T; Guan L; Zhao A; Zhang Y
    J Nutr Health Aging; 2018; 22(3):311-320. PubMed ID: 29484343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethanol-mediated upregulation of APOA1 gene expression in HepG2 cells is independent of de novo lipid biosynthesis.
    Khodja Y; Samuels ME
    Lipids Health Dis; 2020 Jun; 19(1):144. PubMed ID: 32563265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoproteins A1, B, and apoB/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up.
    Bodde MC; Hermans MPJ; Jukema JW; Schalij MJ; Lijfering WM; Rosendaal FR; Romijn FPHTM; Ruhaak LR; van der Laarse A; Cobbaert CM
    Clin Res Cardiol; 2019 May; 108(5):520-538. PubMed ID: 30298424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. V-ATPase (Vacuolar ATPase) Activity Required for ABCA1 (ATP-Binding Cassette Protein A1)-Mediated Cholesterol Efflux.
    Lorkowski SW; Brubaker G; Gulshan K; Smith JD
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2615-2625. PubMed ID: 30354238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ApoB/ApoA1 ratio and non-HDL-cholesterol/HDL-cholesterol ratio are associated to metabolic syndrome in patients with type 2 diabetes mellitus subjects and to ischemic cardiomyopathy in diabetic women.
    Reynoso-Villalpando GL; Sevillano-Collantes C; Valle Y; Moreno-Ruiz I; Padilla-Gutiérrez JR; Del Cañizo-Gómez FJ
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Oct; 66(8):502-511. PubMed ID: 31182348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.